Results 201 to 210 of about 57,342 (256)
Lactate in cardiogenic shock: pathophysiology, prognostic value, and clinical interpretation. [PDF]
Ann Intensive CareLevy B, Hernandez G, Merdji H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cardiology Clinics, 2018
Cardiogenic shock (CS) is a physiologic state in which cardiac pump function is inadequate to perfuse the tissues. If CS is not rapidly recognized and treated, tissue hypoperfusion can quickly lead to organ dysfunction and patient death. Evaluation of patients with suspected CS should include an electrocardiogram, chest radiograph, laboratory studies ...
Semhar Z, Tewelde +2 more
openaire +2 more sources
Cardiogenic shock (CS) is a physiologic state in which cardiac pump function is inadequate to perfuse the tissues. If CS is not rapidly recognized and treated, tissue hypoperfusion can quickly lead to organ dysfunction and patient death. Evaluation of patients with suspected CS should include an electrocardiogram, chest radiograph, laboratory studies ...
Semhar Z, Tewelde +2 more
openaire +2 more sources
Dimensions of Critical Care Nursing, 2008
Despite advances in treatment, the mortality rate of patients who develop cardiogenic shock after an acute myocardial infarction remains unacceptably high. This article presents an overview of cardiogenic shock--incidence, epidemiology, predisposing factors, pathophysiology, and management, both medical and surgical.
Simon, Topalian +2 more
openaire +4 more sources
Despite advances in treatment, the mortality rate of patients who develop cardiogenic shock after an acute myocardial infarction remains unacceptably high. This article presents an overview of cardiogenic shock--incidence, epidemiology, predisposing factors, pathophysiology, and management, both medical and surgical.
Simon, Topalian +2 more
openaire +4 more sources
Cardiology Clinics, 2013
Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often ...
Howard A, Cooper, Julio A, Panza
openaire +2 more sources
Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often ...
Howard A, Cooper, Julio A, Panza
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2000
In the setting of acute myocardial infarction, the timely recognition and treatment of cardiogenic shock are essential in reducing the incidence of death. Patients with cardiogenic shock should be treated aggressively with a combination of pharmacologic agents and mechanical support devices to achieve stabilization. Once stabilization has been achieved,
, Rihner, , Smalling
openaire +2 more sources
In the setting of acute myocardial infarction, the timely recognition and treatment of cardiogenic shock are essential in reducing the incidence of death. Patients with cardiogenic shock should be treated aggressively with a combination of pharmacologic agents and mechanical support devices to achieve stabilization. Once stabilization has been achieved,
, Rihner, , Smalling
openaire +2 more sources
Cardiology Clinics, 1995
Despite advancements in the pharmacologic treatment of acute myocardial infarction and the introduction of mechanical hemodynamic support, in-hospital mortality rates for cardiogenic shock have remained between 70% and 80%. In addition, the proven beneficial effects of thrombolytic therapy in reducing mortality in acute myocardial infarction have not ...
M, Moscucci, E R, Bates
openaire +2 more sources
Despite advancements in the pharmacologic treatment of acute myocardial infarction and the introduction of mechanical hemodynamic support, in-hospital mortality rates for cardiogenic shock have remained between 70% and 80%. In addition, the proven beneficial effects of thrombolytic therapy in reducing mortality in acute myocardial infarction have not ...
M, Moscucci, E R, Bates
openaire +2 more sources
Pediatrics In Review, 2015
Cardiogenic shock is the leading cause of morbidity and mortality in patients presenting with acute coronary syndrome. Although early reperfusion strategies are essential to the management of these critically ill patients, additional treatment plans are often needed to stabilize and treat the patient before reperfusion may be possible.
Sathyaseelan, Subramaniam, Maia, Rutman
openaire +4 more sources
Cardiogenic shock is the leading cause of morbidity and mortality in patients presenting with acute coronary syndrome. Although early reperfusion strategies are essential to the management of these critically ill patients, additional treatment plans are often needed to stabilize and treat the patient before reperfusion may be possible.
Sathyaseelan, Subramaniam, Maia, Rutman
openaire +4 more sources